Search clinical trials for: alcoholic liver cirrhosis

Total 18567 results

Merck Sharp & Dohme LLC

Not yet recruiting

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Non-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Steatohepatitis | Metabolic Dysfunction-associated Steatotic Liver Disease | Metabolic Dysfunction-associated Steatohepatitis
King's College London
King's College Hospital NHS Trust; Imperial College London; Guy's and St Thomas... and other collaborators

Recruiting

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis (PROMISE)

Liver Cirrhosis

United Kingdom
89bio, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

United States
Ali Aminian

Not yet recruiting

Fibrosis Lessens After Metabolic Surgery (FLAMES)

Obesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)

United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
University Hospital, Montpellier
On-call medical home (MMG) Clermont-Hérault

Not yet recruiting

Screening for Chronic Liver Diseases in General Population (HEPGEN)

Fibrosis, Liver

France
University of Bologna

Recruiting

Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis (KETONASH)

Obesity | NAFLD | Liver Fibrosis | NASH

Italy
Hospices Civils de Lyon

Not yet recruiting

Intra-Hepatic Microbiota in Alcoholic Hepatitis (HepMAH)

Cirrhosis | Alcoholic Liver Disease | Alcoholic Hepatitis
Central Hospital, Nancy, France

Not yet recruiting

Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis (HEFITEP)

Non-alcoholic Steatohepatitis
Pichamol Jirapinyo, MD, MPH

Not yet recruiting

ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial

Liver Diseases | Metabolic Diseases | Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Insulin Resistance | Weight Loss | Liver Fat | NAFLD | Insulin Sensitivity/Resistance | Insulin Sensitivity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non Alcoholic Fatty... and other conditions

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study (SARCOLIVER)

Liver Cirrhosis | Hepatocellular Carcinoma | Non-Alcoholic Fatty Liver Disease

Italy
Centre Hospitalier Henri Laborit

Not yet recruiting

Study of Prevalence of Eating Disorder in Liver Transplant Patients (Pré-THETA)

Alcohol Use Disorder | Liver Transplant; Complications | Eating Disorders | Cirrhosis Alcoholic | Eating Disorder Binge

France
Cedars-Sinai Medical Center

Not yet recruiting

Feasibility of Wearable Biosensors for Monitoring Daily Activity, Heart Rate, and Sleep Among Patients With Decompensated Cirrhosis

Liver Cirrhosis, Alcoholic
University of California, San Diego

Recruiting

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM (SAMARA)

Type 2 Diabetes Mellitus in Obese | Fibrosis, Liver | Non-Alcoholic Fatty Liver Disease

United States
Chongqing Medical University

Recruiting

Association of hsCAR With MAFLD and Liver Fibrosis: A Cross-sectional Study

Hepatic Steatosis | Liver Fibrosis | Metabolic Dysfunction-associated Fatty Liver Disease

China
Ruijin Hospital

Recruiting

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) (dSEARCH)

Carcinoma, Hepatocellular | Hepatitis C, Chronic | Hepatitis B, Chronic | Cirrhosis, Liver | Non-Alcoholic Fatty Liver Disease

China
Zealand University Hospital
Aarhus University Hospital; University of Copenhagen; Frederiksberg University... and other collaborators

Recruiting

The Liver Care Trial

Alcoholism | Alcohol-Related Disorders | Fibrosis, Liver | Alcohol Use Disorder | Alcoholic Liver Disease | Alcohol Abuse

Denmark
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.

NAFLD Cirrhosis

India
National Institute of Diabetes and Digestive and...
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Cancer... and other collaborators

Recruiting

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (LCN RESCU)

Cirrhosis | Cirrhosis, Liver | Cirrhosis Due to Hepatitis B | Cirrhosis Due to Hepatitis C | Cirrhosis Early | Cirrhosis Advanced | Cirrhosis Infectious | Cirrhosis Alcoholic | Cirrhosis, Biliary | Cirrhosis Cryptogenic | Cirrhosis Due to Primary Sclerosing Cholangitis

United States
Beijing Friendship Hospital

Recruiting

Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and Steatosis

Chronic Hepatitis b | Non-Alcoholic Fatty Liver Disease

China
Northwestern University
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Cancer... and other collaborators

Recruiting

Liver Cirrhosis Network Cohort Study (LCN-C)

Cirrhosis | Cirrhosis, Liver | Cirrhosis Due to Hepatitis B | Cirrhosis Due to Hepatitis C | Cirrhosis Early | Cirrhosis Advanced | Cirrhosis Infectious | Cirrhosis Alcoholic | Cirrhosis, Biliary | Cirrhosis Cryptogenic | Cirrhosis Due to Primary Sclerosing Cholangitis

United States
University Hospital, Angers

Recruiting

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (SOPRANO)

Liver Fibrosis | Non-alcoholic Fatty Liver Disease (NAFLD) | Alcoholic Liver Disease (ALD)

France
Institut National de la Santé Et de la Recherche...
Centre Hospitalier Universitaire de Nice

Not yet recruiting

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome (CHALNA2)

Hepatocellular Carcinoma | Cirrhosis, Liver | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Alcohol-related Liver Disease
University Hospital, Montpellier

Not yet recruiting

Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit (HEPSY)

Psychiatric Disorder | Liver Fibrosis | Advanced Chronic Liver Disease | Psychiatric Hospitalization

France
Shen Qu

Recruiting

Mechanism of Serum PRL in the Development of MAFLD

Type2 Diabetes | Liver Fibrosis | Fatty Liver, Nonalcoholic

China
VA Office of Research and Development

Recruiting

Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans

Nonalcoholic Steatohepatitis | Liver Fibrosis

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease

NAFLD | Liver Fibrosis | NASH With Fibrosis

Netherlands
F.D. Roosevelt Teaching Hospital with Policlinic...
University Hospital Bratislava; University Hospital Kosice

Not yet recruiting

Screening of Liver Fibrosis in Adults Without Known Liver Disease (SIRIUS)

Liver Fibrosis

Slovakia
Willows Health
Nottingham Trent University

Not yet recruiting

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) (BRANCH-P)

Depression | Heart Diseases | Cardiovascular Diseases | HIV Infections | Obesity | Diabetes | Cancer | Chronic Kidney Diseases | Arthritis | Bulimia | Alzheimer Disease | Cellulitis | Cirrhosis | Eczema | Osteoporosis | Appendicitis | Bronchitis | Bowel Disease | Gout | Alcoholic Liver Disease | Flu | High Cholesterol | Allergies | Indigestion | ... and other conditions

United Kingdom
Dana-Farber Cancer Institute

Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Lung Cancer | Cirrhosis | Barrett Esophagus | Hematologic Malignancy | Non-Alcoholic Fatty Liver Disease | Cancer Risk | Vulvar Intraepithelial Neoplasia | Childhood Cancer Survivors | Lung; Node | Non Alcoholic Steatohepatitis | Osteochondroma | Cancer Predisposition Syndrome | Hereditary Cancer Prediction | Adult... and other conditions

United States
University of Manitoba

Not yet recruiting

Integrating Care for Patients With Alcohol Liver Disease and Alcohol Use Disorders

Alcohol; Liver
University of Kansas Medical Center
Gilead Sciences

Recruiting

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

Fatty Liver | NAFLD

United States
HaEmek Medical Center, Israel
Weizmann Institute of Science

Recruiting

Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.

Fibrosis, Liver | Cirrhosis, Liver | NAFLD - Nonalcoholic Fatty Liver Disease

Israel
Yantai Yuhuangding Hospital

Recruiting

Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells

Alcoholic Cirrhosis

China
E-Scopics

Not yet recruiting

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH (POCUS-NASH)

Liver Diseases | Liver Cirrhosis | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Steatosis of Liver
Pharmicell Co., Ltd.

Recruiting

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Alcoholic Cirrhosis

Korea, Republic of
Anna Cruceta

Recruiting

Efficacy of Simvastatin in Alcoholic Liver Fibrosis (SIMFIB)

Liver Fibrosis | Alcohol Abuse

Spain
University of Aarhus
Odense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaborators

Recruiting

Faecal Microbiota Transplantation for Liver Cirrhosis (CHiFT)

Liver Cirrhosis

Denmark
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis) (FRAMES)

Fibrosis | Cirrhosis | NAFLD | NASH - Nonalcoholic Steatohepatitis | NASH
Brigham and Women's Hospital
Boston Scientific Corporation; American Society for Gastrointestinal Endoscopy

Recruiting

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Obesity | Non-alcoholic Fatty Liver Disease (NAFLD) | Liver Function | Non-alcoholic Steatohepatitis (NASH) | Liver Fibroses | Endoscopic Ultrasound | Endoscopic Sleeve Gastroplasty

United States
Azienda Unità Sanitaria Locale Reggio Emilia

Recruiting

Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients (ImagingNAFLD)

Steatohepatitis, Nonalcoholic | Non-Alcoholic Fatty Liver Disease | Liver Fibroses

Italy
Institut National de la Santé Et de la Recherche...

Not yet recruiting

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". (LivMOD)

Viral Hepatitis C | Liver Cancer | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Chronic Liver Disease and Cirrhosis | Viral Hepatitis B | Viral Hepatitis D
Pharmicell Co., Ltd.

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis (Cellgram-LC)

Alcoholic Cirrhosis

Korea, Republic of
University of Ostrava
University Hospital Ostrava; University Hospital Olomouc; Palacky University

Recruiting

Bariatric Endoscopy and NAFLD

Obesity | NAFLD | Liver Steatosis | Liver Fibrosis

Czechia
Manchester University NHS Foundation Trust
University of Nottingham; University of Manchester; Innovate UK

Recruiting

Integrated Diagnostics for Early Diagnosis of Liver Disease (ID LIVER)

Alcoholic Liver Disease | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Liver Fibroses

United Kingdom
Newcastle University
Assistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaborators

Recruiting

The European NAFLD Registry

Cardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated Comorbidities

Netherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland
Hospices Civils de Lyon

Recruiting

Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology. (NAFLD-CARE)

Non-Alcoholic Fatty Liver Disease

France
Copenhagen University Hospital, Hvidovre
University of Copenhagen

Recruiting

Prospective Cohort Study of Disease and Outcomes in Cirrhosis (ProDoc)

Liver Diseases | Decompensated Cirrhosis | Progression | Liver Cirrhosis, Alcoholic

Denmark
University of California, San Diego

Recruiting

Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference

Nonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver | Liver Inflammation | Liver Fibroses

United States
Indiana University

Recruiting

Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

NASH - Nonalcoholic Steatohepatitis | Cirrhosis, Liver

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies (PROMETEO)

Obesity | Diabetes | Fatty Liver | Metabolic Syndrome | Cirrhosis | NASH - Nonalcoholic Steatohepatitis | Liver Cancer | NAFLD - Nonalcoholic Fatty Liver Disease | HCC - Hepatocellular Carcinoma

Italy

Search clinical trials for: alcoholic liver cirrhosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations